Edition:
India

IPCA Laboratories Ltd (IPCA.NS)

IPCA.NS on National Stock Exchange of India

584.75INR
18 Jan 2018
Change (% chg)

-- (--)
Prev Close
Rs584.75
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
321,564
52-wk High
Rs657.60
52-wk Low
Rs400.00

Chart for

About

Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS... (more)

Overall

Beta: -0.18
Market Cap(Mil.): Rs65,743.43
Shares Outstanding(Mil.): 126.20
Dividend: 1.00
Yield (%): 0.19

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Ipca Laboratories' Units To Acquire Pisgah Labs For $9.65 Mln​​

* SAYS ‍ACQUISITION OF 100 PCT SHARE CAPITAL OF PISGAH LABS INC., NORTH CAROLINA, USA BY COMPANY'S SUBSIDIARIES

17 Jan 2018

BRIEF-India's IPCA Labs Sept-qtr profit up about 76 pct

* Sept quarter profit from continuing operations 964.7 million rupees versus profit of 549.5 million rupees last year

14 Nov 2017

BRIEF-Ipca Labs says The ‍global Fund selected co as panel supplier of anti-malarial medicines

* The ‍global Fund selected co as panel supplier of anti-malarial medicines Source text - http://bit.ly/2zwhueB Further company coverage:

10 Nov 2017

BRIEF-India's Ipca Laboratories posts June-qtr loss

* June quarter loss from continuing operations 202.5 million rupees versus profit of 475.7 million rupees last year

11 Aug 2017

Earnings vs. Estimates